Top

Published in:

2014 | OriginalPaper | Chapter

5. Conclusions and Perspectives

Author : Yu-Chen Hu

Published in: Gene Therapy for Cartilage and Bone Tissue Engineering

Publisher: Springer Berlin Heidelberg

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

Gene therapy has been widely explored for the treatment of various diseases and disorders, yet successful applications of gene therapy in bone and cartilage engineering are still not in the near horizon. This chapter summarizes the major hurdles that set the roadblocks to the application of gene therapy in tissue engineering and discusses future perspectives.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Gene Therapy for Cartilage Tissue Engineering

Evans CH, Ghivizzani SC, Robbins PD (2009) Progress and prospects: genetic treatments for disorders of bones and joints. Gene Ther 16:944–952CrossRef

Evans CH, Ghivizzani SC, Robbins PD (2009) Orthopedic gene therapy in 2008. Mol Ther 17:231–244CrossRef

Seymour LW, Thrasher AJ (2012) Gene therapy matures in the clinic. Nat Biotechnol 30:588–593CrossRef

Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820CrossRef

Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E et al (2006) Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther 13:1290–1299CrossRef

Ishihara A, Shields KM, Litsky AS, Mattoon JS, Weisbrode SE, Bartlett JS et al (2008) Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. J Orthop Res 26:764–771CrossRef

Xu XL, Tang T, Dai K, Zhu Z, Guo XE, Yu C et al (2005) Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop 76:637–646CrossRef

Chen G-Y, Shiah H-C, Su H-J, Chen C-Y, Chuang Y-J, Lo W-H et al (2009) Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 (TLR3) pathway. J Virol 83:10548–10556CrossRef

Chuang C-K, Wong T-H, Hwang S-M, Chang Y-H, Chen Y-H, Chiu Y-C et al (2009) Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. Mol Ther 17:889–896CrossRef

10.

Lin C-Y, Chang Y-H, Lin K-J, Yen T-Z, Tai C-L, Chen C-Y et al (2010) The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 31:3222–3230CrossRef

11.

Lin C-Y, Lin K-J, Kao C-Y, Chen M-C, Yen T-Z, Lo W-H et al (2011) The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 32:6505–6514CrossRef

12.

Lin C-Y, Lin K-J, Li K-C, Sung L-Y, Hsueh S, Lu C-H et al (2012) Immune responses during healing of massive segmental femoral bone defects mediated by hybrid baculovirus-engineered ASCs. Biomaterials 33:7422–7434CrossRef

13.

Colburn NT, Zaal KJM, Wang F, Tuan RS (2009) A role for γ/δ T cells in a mouse model of fracture healing. Arthritis Rheum 60:1694–1703CrossRef

14.

Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X et al (2012) Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med 17:1594–1601CrossRef

15.

Reinke S, Geissler S, Taylor WR, Schmidt-Bleek K, Juelke K, Schwachmeyer V et al (2013) Terminally differentiated CD8+ T cells negatively affect bone regeneration in humans. Sci Transl Med 5:177ra36

16.

Huang S, Kamihira M (2013) Development of hybrid viral vectors for gene therapy. Biotechnol Adv 31:208–223CrossRef

17.

Ho Y-C, Lee H-P, Hwang S-M, Lo W-H, Chen H-C, Chung C-K et al (2006) Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther 13:1471–1479CrossRef

18.

Chen C-Y, Wu H-H, Chen C-P, Chern S-R, Hwang S-M, Huang S-F et al (2011) Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharm 8:1505–1514CrossRef

19.

Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, Ochs BG et al (2006) Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54:3254–3266CrossRef

20.

Mueller MB, Tuan RS (2008) Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58:1377–1388CrossRef

21.

Huey DJ, Hu JC, Athanasiou KA (2012) Unlike bone, cartilage regeneration remains elusive. Science 338:917–921CrossRef

22.

Mahmoudifar N, Doran PM (2012) Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol 30:166–176CrossRef

23.

Afizah H, Yang Z, Hui JH, Ouyang HW, Lee EH (2007) A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 13:659–666CrossRef

24.

Mahmoudifar N, Doran PM (2010) Extent of cell differentiation and capacity for cartilage synthesis in human adult adipose-derived stem cells: comparison with fetal chondrocytes. Biotechnol Bioeng 107:393–401CrossRef

25.

Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F et al (2007) Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211:682–691CrossRef

26.

Lu C-H, Yeh T-S, Yeh C-L, Fang Y-HD, Sung L-Y, Lin S-Y et al (2013) Regenerating cartilages by engineered ASCs: prolonged TGF-β3/BMP-6 expression improved articular cartilage formation and restored zonal structure. Mol Ther 22:186–195

27.

Keeney M, Lai JH, Yang F (2011) Recent progress in cartilage tissue engineering. Curr Opin Biotechnol 25:734–740CrossRef

28.

Madry H, Kaul G, Cucchiarini M, Stein U, Zurakowski D, Remberger K et al (2005) Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12:1171–1179CrossRef

29.

Obradovic B, Martin I, Padera RF, Treppo S, Freed LE, Vunjak-Novakovic G (2001) Integration of engineered cartilage. J Orthop Res 19:1089–1097CrossRef

30.

Mierisch CM, Wilson HA, Turner MA, Milbrandt TA, Berthoux L, Hammarskjold ML et al (2003) Chondrocyte transplantation into articular cartilage defects with use of calcium alginate: the fate of the cells. J Bone Joint Surg Am 85A:1757–1767

31.

Gelse K, Schneider H (2006) Ex vivo gene therapy approaches to cartilage repair. Adv Drug Deliv Rev 58:259–284CrossRef

32.

Grayson WL, Chao P-HG, Marolt D, Kaplan DL, Vunjak-Novakovic G (2008) Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol 26:181–189CrossRef

33.

Chen H-C, Chang Y-H, Chuang C-K, Lin C-Y, Sung L-Y, Wang Y-H et al (2009) The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials 30:674–681CrossRef

34.

Sheyn D, Mizrahi O, Benjamin S, Gazit Z, Pelled G, Gazit D (2010) Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 62:683–698CrossRef

35.

Smith RH, Levy JR, Kotin RM (2009) A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol Ther 17:1888–1896CrossRef

Title: Conclusions and Perspectives
Author: Yu-Chen Hu
Publisher: Springer Berlin Heidelberg
Book: Gene Therapy for Cartilage and Bone Tissue Engineering
Print ISBN: 978-3-642-53922-0

Electronic ISBN: 978-3-642-53923-7

Copyright Year: 2014
DOI: https://doi.org/10.1007/978-3-642-53923-7_5